Genome shuffling of Lactobacillus for improved acid tolerance

Nature Biotechnology
Ranjan PatnaikStephen B del Cardayre


Fermentation-based bioprocesses rely extensively on strain improvement for commercialization. Whole-cell biocatalysts are commonly limited by low tolerance of extreme process conditions such as temperature, pH, and solute concentration. Rational approaches to improving such complex phenotypes lack good models and are especially difficult to implement without genetic tools. Here we describe the use of genome shuffling to improve the acid tolerance of a poorly characterized industrial strain of Lactobacillus. We used classical strain-improvement methods to generate populations with subtle improvements in pH tolerance, and then shuffled these populations by recursive pool-wise protoplast fusion. We identified new shuffled lactobacilli that grow at substantially lower pH than does the wild-type strain on both liquid and solid media. In addition, we identified shuffled strains that produced threefold more lactic acid than the wild type at pH 4.0. Genome shuffling seems broadly useful for the rapid evolution of tolerance and other complex phenotypes in industrial microorganisms.


Mar 1, 1990·Journal of Biotechnology·H KautolaY Y Linko
Jan 1, 1987·Plasmid·L MorelliV Sgaramella
Aug 1, 1986·Journal of Surgical Oncology·D ManfrediF M Sega
Jan 1, 1972·Cold Spring Harbor Symposia on Quantitative Biology·R M StroudR E Dickerson
Nov 15, 1997·Applied and Environmental Microbiology·E O'Sullivan, S Condon
May 9, 1998·Applied and Environmental Microbiology·N W HoA P Brainard
Jun 17, 1998·Applied Biochemistry and Biotechnology·H G Lawford, J D Rousseau
Jun 17, 1998·Applied Biochemistry and Biotechnology·M I DonnellyJ W Rathke
Feb 3, 1999·Annals of the New York Academy of Sciences·L P Wackett
Feb 18, 1999·Current Opinion in Chemical Biology·F H Arnold, A A Volkov
May 29, 1999·Applied and Environmental Microbiology·M Ikeda, R Katsumata
Sep 3, 1999·Applied and Environmental Microbiology·D PorroL Alberghina
Oct 9, 1999·Biotechnology Progress·S Varadarajan, D J Miller
Dec 22, 1999·Current Opinion in Biotechnology·S i Hashimoto, A Ozaki
Dec 22, 1999·Current Opinion in Biotechnology·B Schulze, M G Wubbolts
Feb 7, 2001·Current Opinion in Biotechnology·A Aristidou, M Penttilä
Jul 11, 2000·Nature Biotechnology·Claudia Schmidt-DannertF H Arnold
Aug 10, 2000·Nature Genetics·N W SoongW P Stemmer
Jan 11, 2001·Biochimica Et Biophysica Acta·G ChotaniK Sanford
Jun 21, 2001·Applied Microbiology and Biotechnology·K E JaegerM T Reetz
Jun 29, 2001·Microbiology·M De AngelisM Gobbetti
Jul 5, 2001·International Journal of Medical Microbiology : IJMM·J P AudiaJ W Foster
Feb 8, 2002·Nature·Ying-Xin ZhangStephen B del Cardayre


Dec 4, 2004·Applied Microbiology and Biotechnology·Paolo GiudiciStefano Cassanelli
Oct 18, 2006·Applied Microbiology and Biotechnology·Hiroyuki HidaYasuhiro Yamada
Jan 16, 2007·Applied Microbiology and Biotechnology·Rachel Ruizhen Chen
May 4, 2007·Applied Microbiology and Biotechnology·Takashi YamadaYasuhiro Yamada
Oct 17, 2007·Applied Microbiology and Biotechnology·Toshinari MaedaThomas K Wood
Mar 13, 2008·Applied Microbiology and Biotechnology·Toshinari MaedaThomas K Wood
May 26, 2009·Applied Microbiology and Biotechnology·Yan ZhuYin Li
Aug 23, 2012·Applied Microbiology and Biotechnology·Xing-An LvXinle Liang
Jul 25, 2007·Journal of Industrial Microbiology & Biotechnology·Guo-li GongYue-zhong Li
Oct 11, 2008·Journal of Industrial Microbiology & Biotechnology·Dong-jian ShiKui-ming Wang
Jan 25, 2012·Journal of Industrial Microbiology & Biotechnology·Ge JingpingPing Wenxiang
May 10, 2013·Journal of Industrial Microbiology & Biotechnology·Ji ZhangWensheng Xiang
May 17, 2013·Journal of Industrial Microbiology & Biotechnology·Pu ZhengZhihao Sun
Jan 18, 2011·Antonie van Leeuwenhoek·Mervat M A El-Gendy, Ahmed M A El-Bondkly
Jan 21, 2009·Biotechnology Letters·Lihua Hou
Mar 30, 2010·Biotechnology Letters·James WinklerKaty C Kao
Jul 19, 2012·World Journal of Microbiology & Biotechnology·Xiaohong CaoLihua Hou
Jul 19, 2012·World Journal of Microbiology & Biotechnology·Pu ZhengZhi-Hao Sun
Feb 5, 2008·Science in China. Series C, Life Sciences·Kai ZhaoDongPo Zhou
Jan 10, 2009·Applied Biochemistry and Biotechnology·Z H JinP L Cen
Feb 14, 2009·Applied Biochemistry and Biotechnology·Lihua Hou
May 24, 2013·Applied Biochemistry and Biotechnology·Chao WangXinle Liang
Dec 7, 2007·Molecular Biotechnology·Arnold L Demain, Jose L Adrio
Mar 1, 2010·Indian Journal of Microbiology·Mamta SinghviDigambar V Gokhale
Apr 29, 2005·Biomolecular Engineering·Edward G HibbertPaul A Dalby
Oct 24, 2003·Trends in Biotechnology·Farid E Ahmed
Oct 29, 2003·Current Opinion in Biotechnology·Ryan T Gill
Dec 10, 2002·Current Opinion in Chemical Biology·Haiyan Tao, Virginia W Cornish
Apr 26, 2003·Current Opinion in Chemical Biology·Arjo L de Boer, Claudia Schmidt-Dannert
Aug 28, 2007·The Journal of Antibiotics·Fabrizio BeltramettiFlavia Marinelli
Jul 22, 2009·Nature Chemical Biology·Shelley D Copley
Feb 7, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniel Klein-Marcuschamer, Gregory Stephanopoulos
Jun 29, 2010·Applied and Environmental Microbiology·Daniel Klein-Marcuschamer, Gregory Stephanopoulos
Oct 27, 2009·Applied and Environmental Microbiology·Burkhard OtteStefan Jennewein
Mar 3, 2009·Applied and Environmental Microbiology·Daniel Klein-MarcuschamerGregory Stephanopoulos
Dec 1, 2010·Applied and Environmental Microbiology·Ronnie MachielsenJohan E T van Hylckama Vlieg
Apr 5, 2003·Applied and Environmental Microbiology·Marco Sonderegger, Uwe Sauer

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.